Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases

Pediatr Allergy Immunol. 2024 May;35(5):e14139. doi: 10.1111/pai.14139.

Authors

Stéphanie Wanin¹, Marie Mercier¹, Imane Elaouane¹, Zied Chelly^{2

3}, Mélisande Bourgoin-Heck¹, Nathalie Lambert¹, Serge Doan^{2

4}

Affiliations

¹ Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France.
² Department of Ophthalmology, Bichat Hospital, Groupe Hospitalier Universitaire, AP-HP Nord-University de Paris, Paris, France.
³ Departement of Ophthalmology, Valenciennes Hospital, Valenciennes, France.
⁴ Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France.

PMID: 38753431
DOI: 10.1111/pai.14139

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / therapeutic use
Child
Conjunctivitis, Allergic* / diagnosis
Conjunctivitis, Allergic* / drug therapy
Female
Humans
Interleukin-5* / antagonists & inhibitors
Male
Treatment Outcome